These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4907860)

  • 21. Clinical trial of dipotassium chlorazepate, a new benzodiazepine derivative.
    Juhlin L; Opitz B
    Nord Psykiatr Tidsskr; 1973; 27(1):35-9. PubMed ID: 4569218
    [No Abstract]   [Full Text] [Related]  

  • 22. SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials).
    Itil T; Gannon P; Cora R; Polvan N; Akpinar S; Elveris F; Eskazan E
    Behav Neuropsychiatry; 1972; 4(4-5):15-24. PubMed ID: 4566673
    [No Abstract]   [Full Text] [Related]  

  • 23. Clorazepate (tranxene). Another benzodiazepine.
    Med Lett Drugs Ther; 1972 Nov; 14(23):85-6. PubMed ID: 4630756
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of the anxiolytic efficacy of lorazepam (WY 4036) and diazepam (Valium)].
    De Buck R; Boon H; Pelc I
    Acta Psychiatr Belg; 1972 Mar; 72(2):185-98. PubMed ID: 4560256
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts.
    Sugerman AA; Miksztal MW; Freymuth HW
    J Clin Pharmacol New Drugs; 1971; 11(5):383-7. PubMed ID: 4935717
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical and computerized EEG effects of U-31,920, a new anxiolytic.
    Itil TM; Akpinar S; Ozkut H; Balki N; Herrmann WM
    Curr Ther Res Clin Exp; 1974 Jun; 16(6):642-54. PubMed ID: 4211146
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of a new tranquillizer--WY 4036--in the treatment of anxiety.
    Haider I
    Br J Psychiatry; 1971 Dec; 119(553):597-8. PubMed ID: 4947166
    [No Abstract]   [Full Text] [Related]  

  • 28. Benzoctamine and medazepam in treatment of anxiety of children and adolescents: a comparative study.
    Dahlström H; Fedor-Freybergh P; Kåreland H; Vahlne L
    Acta Psychiatr Scand; 1973 Jul; 49(6):735-43. PubMed ID: 4592708
    [No Abstract]   [Full Text] [Related]  

  • 29. [Extension of therapeutic possibilities by a new tranquilizer].
    Leube H
    Arzneimittelforschung; 1968 Dec; 18(12):1566-8. PubMed ID: 5756250
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical effect of nitrazepam on psychoneurosis with insomnia].
    Kaneko J; Takaishi N; Ida H; Abe H; Hosaka M
    Saishin Igaku; 1969 Oct; 24(10):2142-8. PubMed ID: 4900118
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience with the new tranquilizing agent Wy 4036 (lorazepam) in the specialties psychiatric neurology and internal medicine].
    Leube H; Höffkes H
    Arzneimittelforschung; 1971 Jul; 21(7):1098-102. PubMed ID: 5109550
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative evaluation of the effect of minor tranquilizers, benzodiazepine derivatives, medazepam (S-804) and diazepam on psychosomatic symptoms--estimtion of dosage ratio by the double blind method].
    Fukuda I; Kamide H; Higuchi H; Fujiwara K; Nakamura Y
    Saishin Igaku; 1971 Aug; 26(8):1564-7. PubMed ID: 4936623
    [No Abstract]   [Full Text] [Related]  

  • 33. Clorazepate dipotassium in anxiety: a clinical trial with diazepam and placebo controls.
    Ricca JJ
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):286-90. PubMed ID: 4557537
    [No Abstract]   [Full Text] [Related]  

  • 34. [The neuropsychopharmacological drugs in dentistry: clinical-experimental study].
    Bernardini UD; Huober G; Pini Prato G
    Riv Ital Stomatol; 1969 Oct; 24(10):993-1000. PubMed ID: 4909760
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of dipotassium clorazepate in combination with insulin in the treatment of depressive states].
    Guyot MP
    Ann Med Psychol (Paris); 1974 May; 1(5):627-31. PubMed ID: 4433108
    [No Abstract]   [Full Text] [Related]  

  • 36. Chlordiazepoxide and dothiepin compared in anxiety-depression in general practice.
    Johnson F; Sacco FA; Yellowley TW
    Practitioner; 1973 Sep; 211(263):362-4. PubMed ID: 4586237
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of psychoneurosis by medazepam--with special reference to therapy of disorders of autonomic nervous system].
    Toru M; Shimazono Y
    Saishin Igaku; 1971 Mar; 26(3):553-62. PubMed ID: 4926344
    [No Abstract]   [Full Text] [Related]  

  • 38. [Medazepam. A new tranquilizer: simple test, intraindividual comparisons and combination therapy].
    Spiegelberg U; Petrilowitsch N; Betz B
    Arzneimittelforschung; 1968 Dec; 18(12):1559-63. PubMed ID: 5756249
    [No Abstract]   [Full Text] [Related]  

  • 39. Preliminary experience with medazepam (nobrium) in the management of psychophysiologic reactions.
    Brandsma M
    Psychosomatics; 1970; 11(3):197-200. PubMed ID: 5427134
    [No Abstract]   [Full Text] [Related]  

  • 40. Clorazepate dipotassium in anxiety: a double-blind trial with diazepam controls.
    Wiersum J
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):442-8. PubMed ID: 4629306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.